Results 171 to 180 of about 148,724 (217)

Discovery of Potent and Orally Bioavailable Heterocycle-Based Cannabinoid CB1 Receptor Agonists

open access: yesBioorganic and Medicinal Chemistry Letters, 2011
Novel 3-(1H-indol-3-yl)-1,2,4-oxadiazoles and -thiadiazoles were synthesized and found to be potent CB1 cannabinoid receptor agonists. The oral bioavailability of these compounds could be dramatically improved by optimization studies of the side chains ...
Grant Wishart   +2 more
exaly   +5 more sources

Design, Synthesis, and Structure–Activity Relationship Study of Conformationally Constrained Analogs of Indole-3-Carboxamides as Novel CB1 Cannabinoid Receptor Agonists

open access: yesBioorganic and Medicinal Chemistry Letters, 2010
Novel tricyclic indole-3-carboxamides were synthesized as structurally restricted analogs of bicyclic indoles, and found to be potent CB1 cannabinoid receptor agonists.
Mark York, Glenn Walker, Darren Edwards
exaly   +5 more sources

Oximes short-acting CB1 receptor agonists

Bioorganic & Medicinal Chemistry, 2018
New oximes short-acting CB1 agonists were explored by the introduction of an internal oxime and polar groups at the C3 alkyl tail of Δ8-THC. The scope of the research was to drastically alter two important physicochemical properties hydrophobicity (log P) and topological surface area (tPSA) of the compound, which play a critical role in tissue ...
Michael S. Malamas   +8 more
openaire   +2 more sources

AM630 is an inverse agonist at the human cannabinoid CB1 receptor

Life Sciences, 1998
The present investigation examines WIN 55,212-2 and AM630 at the cloned human cannabinoid CB1 receptor stably expressed in Chinese hamster ovary (CHO) cells. The effect of various concentrations of WIN 55,212-2 and AM630 on basal [35S]GTPgammaS binding to cell membranes was determined.
R S, Landsman   +5 more
openaire   +2 more sources

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

European Journal of Pharmacology, 1997
The effects of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4- benzoxazin-yl]-(1-napthalenyl)methanone mesylate (WIN 55,212-2) and N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazo le-carboxamide (SR141716A) on guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding to membranes isolated from ...
R S, Landsman   +4 more
openaire   +2 more sources

Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists

CNS & Neurological Disorders - Drug Targets, 2011
Cannabinoids are antinociceptive in animal models of acute pain, tissue injury and nerve injury induced nociception and act via their cognate receptors, cannabinoid receptor 1 and 2. This review examines the underlying biology of the endocannabinoids and behavioural, neurophysiological, neuroanatomical evidence supporting the notion of pain modulation ...
Rashmi, Talwar, Vijay Kumar, Potluri
openaire   +2 more sources

Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists

Bioorganic & Medicinal Chemistry Letters, 2005
Structure-activity relationship studies for two series of 2-benzyloxy-5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)pyridines having either a 3-cyano or 3-carboxamide moiety resulted in the preparation of the 2-(3,4-difluorobenzyloxy)-3-nitrile analog 10d and the 2-(3,4-difluorobenzyloxy)-3-(N-propylcarboxamide) analog 16c, (hCB1 IC(50)=1.3 and 1.7 nM ...
Laura C, Meurer   +17 more
openaire   +3 more sources

Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists

Psychopharmacology, 2006
Cannabinoid CB1 receptors are expressed in the prefrontal cortex, but their role in mediating executive functions such as behavioral flexibility is unclear.The present study examined the effect of pharmacological activation or blockade of the cannabinoid CB1 receptors on behavioral flexibility using a strategy set-shifting task conducted on a cross ...
Matthew N, Hill   +4 more
openaire   +2 more sources

Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain

European Journal of Pharmacology, 1997
We measured (-)-5-(1,1-dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohe xyl]-phenol (CP 55,940)-, (-)11-OH-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210)-, anandamide- and delta9-tetrahydrocannabinol-stimulated G protein activation in mouse brain using the [35S]GTPgammaS functional assay.
T H, Burkey   +6 more
openaire   +2 more sources

Discovery of a novel class of selective human CB1 inverse agonists

Bioorganic & Medicinal Chemistry Letters, 2008
Ligand-based virtual screening led to the discovery of a new class of potent inverse agonists of the human cannabinoid receptor 1, hCB(1), which are selective versus hCB(2). These CB(1) ligands present intriguing departures from a classical CB(1) antagonist pharmacophore. Elements of SAR are discussed in this context.
Nicolas, Foloppe   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy